Clinical Trials Browser

Phase 1 × Renal Insufficiency × 30 days × Clear all

NCT07154901 2026-05-22

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Phase 1 Active not recruiting

Lymphoma, Follicular, Renal Insufficiency